XML 17 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Feb. 25, 2023
Feb. 26, 2022
Feb. 27, 2021
Income Statement [Abstract]      
Net sales $ 5,344,685 $ 7,867,778 $ 9,233,028
Cost of sales 4,129,802 5,384,287 6,114,947
Gross profit 1,214,883 2,483,491 3,118,081
Selling, general and administrative expenses 2,372,969 2,692,292 3,224,363
Impairments 1,287,529 36,531 127,341
Restructuring and transformation initiative expenses 330,024 144,025 102,202
Loss on sale of businesses 0 18,221 1,062
Operating loss (2,775,639) (407,578) (336,887)
Interest expense, net 110,497 64,702 76,913
Loss on preferred stock warrants and derivative liabilities 639,444 0 0
Loss on deconsolidation of subsidiaries 98,633 0 0
Loss (gain) on extinguishment of debt (94,343) 376 (77,038)
Loss before provision (benefit) from income taxes (3,529,870) (472,656) (336,762)
Provision (benefit) from income taxes (31,069) 86,967 (185,989)
Net loss $ (3,498,801) $ (559,623) $ (150,773)
Net loss per share - Basic (in dollars per share) $ (36.03) $ (5.64) $ (1.24)
Net loss per share - Diluted (in dollars per share) $ (36.03) $ (5.64) $ (1.24)
Weighted average shares outstanding - Basic (in shares) 97,106 99,249 121,446
Weighted average shares outstanding - Diluted (in shares) 97,106 99,249 121,446